Literature DB >> 15464672

Determinants of atrial fibrillation development in patients with hypertrophic cardiomyopathy.

Maria-Angela Losi1, Sandro Betocchi, Mariano Aversa, Raffaella Lombardi, Marianna Miranda, Gianluigi D'Alessandro, Alessandra Cacace, Carlo-Gabriele Tocchetti, Giovanni Barbati, Massimo Chiariello.   

Abstract

Predictors of the development of atrial fibrillation (AF) in patients who have hypertrophic cardiomyopathy (HC) have not been extensively studied, although, in these patients, AF contributes to the exacerbation of symptoms and the development of heart failure. The present study determined the role of left atrial (LA) function in the development of AF in patients who have HC. One hundred fifty consecutive patients who had HC, had no history of AF, and who were followed for 5.2 +/- 2.9 years constituted the study population. Using M-mode echocardiography, we measured LA function as global LA fractional shortening and LA diameter. LA volume was measured from 2-dimensional 4-chamber views by the method of disks. During follow-up, 20 patients developed AF. LA function was an independent predictor of AF (odds ratio 0.716, p = <0.001), whereas LA diameter and volume were predictors in addition to age. Kaplan-Meier analysis showed that LA dysfunction carried a high risk of AF. Thus, in patients who have HC, LA function is a strong predictor of AF development and is independent of age.

Entities:  

Mesh:

Year:  2004        PMID: 15464672     DOI: 10.1016/j.amjcard.2004.06.024

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  31 in total

Review 1.  Assessment of left atrial volume: a focus on echocardiographic methods and clinical implications.

Authors:  Chee W Khoo; Suresh Krishnamoorthy; Hoong Sern Lim; Gregory Y H Lip
Journal:  Clin Res Cardiol       Date:  2010-09-07       Impact factor: 5.460

2.  Left atrial wall thickness and outcomes of catheter ablation for atrial fibrillation in patients with hypertrophic cardiomyopathy.

Authors:  Hiroshi Hayashi; Meiso Hayashi; Yasushi Miyauchi; Kenta Takahashi; Shunsuke Uetake; Ippei Tsuboi; Kenji Yodogawa; Yu-Ki Iwasaki; Wataru Shimizu
Journal:  J Interv Card Electrophysiol       Date:  2014-04-25       Impact factor: 1.900

Review 3.  A primer on arrhythmias in patients with hypertrophic cardiomyopathy.

Authors:  Katy E Bockstall; Mark S Link
Journal:  Curr Cardiol Rep       Date:  2012-10       Impact factor: 2.931

4.  Atrial Fibrillation and Anticoagulation in Hypertrophic Cardiomyopathy.

Authors:  C Fielder Camm; A John Camm
Journal:  Arrhythm Electrophysiol Rev       Date:  2017-06

Review 5.  Atrial fibrillation and hypertrophic cardiomyopathy: who to anticoagulate?

Authors:  Antonio Frontera; D G Wilson; H Sekhon; E R Duncan; G Thomas
Journal:  Clin Res Cardiol       Date:  2015-07-02       Impact factor: 5.460

6.  Comparison of echocardiographic single-plane versus biplane method in the assessment of left atrial volume and validation by real time three-dimensional echocardiography.

Authors:  Cesare Russo; Rebecca T Hahn; Zhezhen Jin; Shunichi Homma; Ralph L Sacco; Marco R Di Tullio
Journal:  J Am Soc Echocardiogr       Date:  2010-07-21       Impact factor: 5.251

7.  Factors associated with the development of atrial fibrillation in patients with rheumatic mitral stenosis.

Authors:  Mehmet Ozaydin; Yasin Turker; Ercan Varol; Sule Alaca; Dogan Erdogan; Nigar Yilmaz; Abdullah Dogan
Journal:  Int J Cardiovasc Imaging       Date:  2010-03-24       Impact factor: 2.357

Review 8.  Echocardiography in patients with hypertrophic cardiomyopathy: usefulness of old and new techniques in the diagnosis and pathophysiological assessment.

Authors:  Maria-Angela Losi; Stefano Nistri; Maurizio Galderisi; Sandro Betocchi; Franco Cecchi; Iacopo Olivotto; Eustachio Agricola; Piercarlo Ballo; Simona Buralli; Antonello D'Andrea; Arcangelo D'Errico; Donato Mele; Susanna Sciomer; Sergio Mondillo
Journal:  Cardiovasc Ultrasound       Date:  2010-03-17       Impact factor: 2.062

9.  Incidence of Atrial Fibrillation following Alcohol Septal Ablation for Hypertrophic Cardiomyopathy.

Authors:  Travis J Moss; Matthew M Zipse; Mori J Krantz; William H Sauer; Ernesto E Salcedo; Joseph L Schuller
Journal:  Ann Noninvasive Electrocardiol       Date:  2016-03-11       Impact factor: 1.468

10.  CMR findings in patients with hypertrophic cardiomyopathy and atrial fibrillation.

Authors:  Theano Papavassiliu; Tjeerd Germans; Stephan Flüchter; Christina Doesch; Anton Suriyakamar; Dariusch Haghi; Tim Süselbeck; Christian Wolpert; Dietmar Dinter; Stefan O Schoenberg; Albert C van Rossum; Martin Borggrefe
Journal:  J Cardiovasc Magn Reson       Date:  2009-09-09       Impact factor: 5.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.